Herbal granules aim to stop AFib recurrence after heart procedure
NCT ID NCT07508618
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether Qidong Yixin Granules, an herbal medicine, can reduce the chance of atrial fibrillation returning within a year after a standard heart ablation procedure. About 846 adults with persistent atrial fibrillation will be randomly assigned to receive either the granules or a placebo for 12 months. Researchers will track heart rhythm with ECGs and Holter monitors at regular follow-ups.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Qidong Yixin Granules (herbal granules)
What this could lead to
If it works, this could provide a new herbal option to help prevent atrial fibrillation from coming back after a standard ablation procedure.
What could go wrong
This is a phase 4 trial, but the intervention is an herbal product with limited prior evidence. The placebo group helps control for bias, but results may not apply to all patients or settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Deqing People'S Hospital
NOT_YET_RECRUITINGHuzhou, China
Contact Phone: •••-•••-••••
Contact
-
Ningbo No.2 Hospital
NOT_YET_RECRUITINGNingbo, China
Contact
Contact Phone: •••-•••-••••
-
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
RECRUITINGHangzhou, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
The First Affiliated Hospital, Zhejiang University School of Medicine
NOT_YET_RECRUITINGHangzhou, China
Contact Phone: •••-•••-••••
Contact
-
The Second Affiliated Hospital Zhejiang University School of Medicine
NOT_YET_RECRUITINGHangzhou, China
Contact
Contact Phone: •••-•••-••••